Financhill
Back

Aquestive Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
63

AQST
Aquestive Therapeutics

Last Price:
5.15
Seasonality Move:
-3.4%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Aquestive Therapeutics Price Quote

$5.15

Aquestive Therapeutics Key Stats

Buy
63
Aquestive Therapeutics (AQST) is a Buy

Day range:
$5.12 - $5.52
52-week range:
$1.52 - $6.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.54
P/B ratio:
0%

Volume:
1.9M
Avg. volume:
1.3M
1-year change:
221.88%
Market cap:
$469M
Revenue:
$50.6M
EPS:
$-0.36

How Much Does Aquestive Therapeutics Make?

Is Aquestive Therapeutics Growing As A Company?

Aquestive Therapeutics Stock Price Performance

What Is Aquestive Therapeutics 52-Week High & Low?

Aquestive Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Aquestive Therapeutics?

Is Aquestive Therapeutics Cash Flow Positive?

  • What Is AQST Cash Flow From Operations?
    Cash flow from operations (TTM) is -$24.7M
  • What Is Aquestive Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $92.3M
  • What Is Aquestive Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$231K

Aquestive Therapeutics Return On Invested Capital

Data Unavailable

Aquestive Therapeutics Earnings Date & Stock Price

Aquestive Therapeutics Competitors

Aquestive Therapeutics Dividend Yield

Aquestive Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 88.33%
Revenue: 51.79% 62.35%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 9.56
Upside from Last Price: 85.68%

Major Shareholders

  • How many AQST shares are owned by institutional investors?
    68.3M AQST shares are owned by institutional investors
  • How many AQST shares are owned by insiders?
    4.7M AQST shares are owned by insiders